These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26335533)

  • 21. A Novel PSMA-Targeted Probe for NIRF-Guided Surgery and Photodynamic Therapy: Synthesis and Preclinical Validation.
    Capozza M; Stefania R; Dinatale V; Bitonto V; Conti L; Grange C; Skovronova R; Terreno E
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer.
    Benešová M; Schäfer M; Bauder-Wüst U; Afshar-Oromieh A; Kratochwil C; Mier W; Haberkorn U; Kopka K; Eder M
    J Nucl Med; 2015 Jun; 56(6):914-20. PubMed ID: 25883127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PSMA-mediated endosome escape-accelerating polymeric micelles for targeted therapy of prostate cancer and the real time tracing of their intracellular trafficking.
    Gao Y; Li Y; Li Y; Yuan L; Zhou Y; Li J; Zhao L; Zhang C; Li X; Liu Y
    Nanoscale; 2015 Jan; 7(2):597-612. PubMed ID: 25419788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen for molecular imaging of prostate cancer.
    Hillier SM; Maresca KP; Lu G; Merkin RD; Marquis JC; Zimmerman CN; Eckelman WC; Joyal JL; Babich JW
    J Nucl Med; 2013 Aug; 54(8):1369-76. PubMed ID: 23733925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PSMA-Targeted Theranostic Nanocarrier for Prostate Cancer.
    Flores O; Santra S; Kaittanis C; Bassiouni R; Khaled AS; Khaled AR; Grimm J; Perez JM
    Theranostics; 2017; 7(9):2477-2494. PubMed ID: 28744329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-Circulating Prostate-Specific Membrane Antigen-Targeted NIR Phototheranostic Agent.
    Overchuk M; Damen MPF; Harmatys KM; Pomper MG; Chen J; Zheng G
    Photochem Photobiol; 2020 May; 96(3):718-724. PubMed ID: 31742696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PSMA-targeting iron oxide magnetic nanoparticles enhance MRI of preclinical prostate cancer.
    Tse BW; Cowin GJ; Soekmadji C; Jovanovic L; Vasireddy RS; Ling MT; Khatri A; Liu T; Thierry B; Russell PJ
    Nanomedicine (Lond); 2015 Feb; 10(3):375-86. PubMed ID: 25407827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and preclinical targeted alpha therapy of human prostate cancer with Bi-213 labeled J591 antibody against the prostate specific membrane antigen.
    Li Y; Tian Z; Rizvi SM; Bander NH; Allen BJ
    Prostate Cancer Prostatic Dis; 2002; 5(1):36-46. PubMed ID: 15195129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel anti-PSMA human scFv has the potential to be used as a diagnostic tool in prostate cancer.
    Han D; Wu J; Han Y; Wei M; Han S; Lin R; Sun Z; Yang F; Jiao D; Xie P; Zhang L; Yang AG; Zhao A; Wen W; Qin W
    Oncotarget; 2016 Sep; 7(37):59471-59481. PubMed ID: 27448970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving the biodistribution of PSMA-targeting tracers with a highly negatively charged linker.
    Huang SS; Wang X; Zhang Y; Doke A; DiFilippo FP; Heston WD
    Prostate; 2014 May; 74(7):702-13. PubMed ID: 24615708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of polymeric microbubbles targeted to prostate-specific membrane antigen as prototype of novel ultrasound contrast agents.
    Sanna V; Pintus G; Bandiera P; Anedda R; Punzoni S; Sanna B; Migaleddu V; Uzzau S; Sechi M
    Mol Pharm; 2011 Jun; 8(3):748-57. PubMed ID: 21545176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A PSMA-targeted theranostic agent for photodynamic therapy.
    Chen Y; Chatterjee S; Lisok A; Minn I; Pullambhatla M; Wharram B; Wang Y; Jin J; Bhujwalla ZM; Nimmagadda S; Mease RC; Pomper MG
    J Photochem Photobiol B; 2017 Feb; 167():111-116. PubMed ID: 28063300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Vivo Molecular MRI Imaging of Prostate Cancer by Targeting PSMA with Polypeptide-Labeled Superparamagnetic Iron Oxide Nanoparticles.
    Zhu Y; Sun Y; Chen Y; Liu W; Jiang J; Guan W; Zhang Z; Duan Y
    Int J Mol Sci; 2015 Apr; 16(5):9573-87. PubMed ID: 25927579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual contrast agents for fluorescence and photoacoustic imaging: evaluation in a murine model of prostate cancer.
    Lesniak WG; Wu Y; Kang J; Boinapally S; Ray Banerjee S; Lisok A; Jablonska A; Boctor EM; Pomper MG
    Nanoscale; 2021 May; 13(20):9217-9228. PubMed ID: 33978042
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Zhao Y; Fletcher NL; Liu T; Gemmell AC; Houston ZH; Blakey I; Thurecht KJ
    Nanotheranostics; 2018; 2(4):360-370. PubMed ID: 30324082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design of Internalizing PSMA-specific Glu-ureido-based Radiotherapeuticals.
    Wüstemann T; Bauder-Wüst U; Schäfer M; Eder M; Benesova M; Leotta K; Kratochwil C; Haberkorn U; Kopka K; Mier W
    Theranostics; 2016; 6(8):1085-95. PubMed ID: 27279903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PSMA-targeted stably linked "dendrimer-glutamate urea-methotrexate" as a prostate cancer therapeutic.
    Huang B; Otis J; Joice M; Kotlyar A; Thomas TP
    Biomacromolecules; 2014 Mar; 15(3):915-23. PubMed ID: 24392665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.
    Chang SS; Reuter VE; Heston WD; Bander NH; Grauer LS; Gaudin PB
    Cancer Res; 1999 Jul; 59(13):3192-8. PubMed ID: 10397265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical evaluation of a bispecific low-molecular heterodimer targeting both PSMA and GRPR for improved PET imaging and therapy of prostate cancer.
    Eder M; Schäfer M; Bauder-Wüst U; Haberkorn U; Eisenhut M; Kopka K
    Prostate; 2014 May; 74(6):659-68. PubMed ID: 24464532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PSMA Ligands for Radionuclide Imaging and Therapy of Prostate Cancer: Clinical Status.
    Lütje S; Heskamp S; Cornelissen AS; Poeppel TD; van den Broek SA; Rosenbaum-Krumme S; Bockisch A; Gotthardt M; Rijpkema M; Boerman OC
    Theranostics; 2015; 5(12):1388-401. PubMed ID: 26681984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.